Chrome Extension
WeChat Mini Program
Use on ChatGLM

Gilteritinib-Based Combinations Improve Survival and Enhance Allogenic Transplant Eligibility in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML): Canadian Single-Center Experience

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2024)

Cited 0|Views0
Key words
AML,FLT3,relapsed-refractory,gilteritinib,venetoclax
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined